Lead sponsor
Emory University
6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
6
Trials led
1
Active
632
Total enrollment
6
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
2
Phase 4
4
Trials by status
Not yet recruiting
1
Completed
3
Terminated
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 DiabetesBMI 25-45Ph 4Completed150
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery PatientsBMI ≥25Ph 4Terminated28